Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis

Blau syndrome is a systemic autoinflammatory granulomatous disease caused by mutations in the nucleotide-binding oligomerization domain 2 (NOD2) gene. NOD2 is an intracellular pathogen recognition receptor. Upon binding to muramyl dipeptide (MDP), NOD2 activates the NF-κB pathway, leading to the upr...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuda, Tomoko, Kambe, Naotomo, Takimoto-Ito, Riko, Ueki, Yoko, Nakamizo, Satoshi, Saito, Megumu K., Takei, Syuji, Kanazawa, Nobuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195515/
https://www.ncbi.nlm.nih.gov/pubmed/35711422
http://dx.doi.org/10.3389/fimmu.2022.895765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195515/
https://www.ncbi.nlm.nih.gov/pubmed/35711422
http://dx.doi.org/10.3389/fimmu.2022.895765

Ejemplares similares